# RIFAMPIN
> **ANDA090034** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN PHARMS · Approved 2013-08-21
## Drug
- **FDA Application Number:** ANDA090034
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAMPIN
- **Generic name:** RIFAMPIN
- **Active ingredients:** RIFAMPIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUPIN PHARMS
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2013-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090034)
---
*MORVS · CC0 1.0*